These five companies sell the same underlying thing in different wrappers: other people's work. Concentrix, based in Fremont, California, runs outsourced customer-service and back-office operations with 455,000 employees. Genpact, spun out of General Electric and now registered in Bermuda, runs finance, procurement and supply-chain operations for large corporates with 145,000 staff. ExlService handles claims, underwriting and analytics for insurers and healthcare payers. NIQ Global Intelligence sells consumer-measurement and shopper-panel data to brands. Innodata, the outlier, labels and curates the training data that large language models are built on — it is paid to build the software that could eventually delete the seats the other four bill for.

The gain has a date stamp

Almost the entire monthly move landed between 22 and 29 July. Concentrix rose 11.9% on 27 July; Genpact rose 15.3% into 28 July and 6.1% more the next day; NIQ rose 6.1% on 27 July; ExlService went from $28.56 to $35.71 in two sessions. The trigger was not company news. Jefferies upgraded Indian information-technology services from underweight to neutral on 27 July on explicitly tactical grounds, still forecasting only low-to-mid single-digit revenue growth through fiscal 2028. In the same month India's Nifty IT index gained 16.7% while the Philadelphia semiconductor index fell 21%, the widest monthly gap since 1999, as funds rotated out of crowded artificial-intelligence chip positions. Since 29 July the group has given ground: Genpact −6.6%, NIQ −2.4%, ExlService −2.3%, Concentrix −2.1%.

Two businesses are confirming

ExlService is the cleanest. Revenue growth has accelerated four straight quarters — 12.2%, 12.7%, 13.8%, 15.6% — to $594.8m, gross profit grew faster than revenue at 16.4%, and management raised full-year guidance to $2.39–2.415bn with data- and AI-led services at 61% of revenue. The blemish: operating margin fell from 15.77% to 14.68% and net income declined 2.3%. At 14.96x forward earnings against 21.53x trailing — and roughly 27.6x trailing at the end of 2025 — the de-rating is real. Business verdict: CONFIRMS. Valuation: CONFIRMS.

Genpact is the divergence. Second-quarter revenue rose 7.1% to $1.343bn, adjusted earnings per share 13.6%, and Advanced Technology Solutions revenue 24.1% to 27% of the total, with full-year growth guidance for that unit lifted to at least 25% from at least 20%. Gross margin widened to 36.50% from 35.88%. The stock fell 5.17% the following session. It trades at 8.42x forward and 10.09x trailing earnings, 7.52x enterprise value to EBITDA, with a 9.8% free-cash-flow yield — against roughly 14.9x trailing at the end of 2025, on higher earnings. Business verdict: CONFIRMS; the tape does not.

Two are contradicting, in opposite directions

Concentrix bounced 20% on deteriorating numbers. Revenue growth decelerated to 1.9%, gross profit fell 2.9%, operating income fell 35.7% and operating margin halved to 3.88%. Management cut full-year adjusted earnings guidance to $10.83–11.18 from $11.48–12.07, citing a three-point revenue drag from clients moving work offshore faster than planned. It carries a $1,523.3m goodwill write-off against the $4.8bn Webhelp acquisition and 3.2x leverage. At 2.27x forward earnings, 0.56x book and a 33.7% free-cash-flow yield, the market is priced for terminal decline; the quarter did not refute it. Business: CONTRADICTS.

Innodata is the inverse. Second-quarter revenue rose 58% to a record $92.1m with 49% adjusted gross margin and adjusted EBITDA up 92%, full-year growth guidance of 40%-plus reiterated, and largest-customer concentration down to 37% from 56%, alongside an announced chief-executive transition. The shares are down roughly 49% from their 4 June peak. At 58.6x forward earnings and 5.79x forward sales, the de-rating is of the multiple, not the business.

NIQ is unresolved: first-quarter revenue grew 1.3% with a $90.1m net loss, $3.2bn net debt at 3.4x leverage and reaffirmed 5.0–5.3% organic growth guidance. Second-quarter results are due after the close on 10 August. INCONCLUSIVE.

On the tape, ExlService and NIQ cleared their downtrends on 28 July and Genpact on 3 August, its 50-day average turning up. Concentrix never repaired — it remains in its steepest downtrend despite the bounce — and Innodata was downgraded twice, on 10 and 28 July.

The setup

Where it stands — A late-July rotation lifted all five; only ExlService and Genpact have earnings that match the move. Would confirm — Genpact recovering the 5.17% post-earnings drop and holding above its 50-day average through September. Would invalidate — Concentrix's next quarter showing revenue growth below 1.9% or further cuts to $10.83–11.18 guidance. Watch next — NIQ's second-quarter results after the close on 10 August 2026, against 5.0–5.3% organic growth guidance. Valuation — Genpact 8.42x forward vs 10.09x trailing and ~14.9x at end-2025; Innodata 58.6x forward.